CAS 1158279-20-9

9H-Carbazole-3-methanamine, 9-ethyl-N-[(2-methoxyphenyl)methyl]-, hydrochloride (1:1)

CAS : 1158279-20-9

Formule : C₂₃H₂₅ClN₂O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 380.9104

Ref: IN-DA000GX9

HLCL-61 hydrochloride

CAS : 1158279-20-9

HLCL-61 hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 380.91g/mol

Ref: 54-BUP13308

HLCL-61 hydrochloride

CAS : 1158279-20-9

HLCL-61 hydrochloride (HLCL-61 HCL) is a potent and selective PRMT5 inhibitor for the treatment of acute myeloid leukemia.

Formule : C₂₃H₂₄N₂O·ClH

Degré de pureté : 99.88% - 99.95%

Couleur et forme : Solid

Masse moléculaire : 380.91

Ref: TM-T6857

1-(9-Ethyl-9H-carbazol-3-yl)-N-(2-methoxybenzyl)methanamine hydrochloride

CAS : 1158279-20-9

Degré de pureté : 99%

Masse moléculaire : 380.9200134

Ref: 10-F870090

HLCL-61 HCL

CAS : 1158279-20-9

HLCL-61 HCL is an analog of the natural amino acid histidine. It is used as a hematologic agent in cellular proliferation studies and to inhibit cellular protein synthesis. The synthesis of HLCL-61 HCL can be achieved through two methods: (1) by reacting L-histidine with oxalyl chloride; or (2) by reacting L-histidine methyl ester with ammonia and sodium hydroxide. HLCL-61 HCL has been shown to act as a competitive inhibitor of the enzyme arginase, which catalyzes the conversion of arginine to urea and ornithine. This effect may be due to its ability to compete with hydroxylamine for binding sites on the enzyme.

Formule : C₂₃H₂₄N₂O·HCl

Degré de pureté : Min. 95%

Masse moléculaire : 380.91 g/mol

Ref: 3D-IWB27920